Squarepoint’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-62,618
| Closed | -$936K | – | 4019 |
|
|
2022
Q4 | $936K | Buy |
+62,618
| New | +$867K | ﹤0.01% | 1869 |
|
|
2021
Q2 | – | Sell |
-23,803
| Closed | -$174K | – | 4014 |
|
|
2021
Q1 | $174K | Sell |
23,803
-86,376
| -78% | -$745K | ﹤0.01% | 2752 |
|
|
2020
Q4 | $636K | Buy |
110,179
+33,447
| +44% | +$191K | ﹤0.01% | 1628 |
|
|
2020
Q3 | $456K | Sell |
76,732
-40,978
| -35% | -$203K | 0.01% | 1505 |
|
|
2020
Q2 | $606K | Buy |
+117,710
| New | +$743K | 0.01% | 1201 |
|
|
2019
Q4 | – | Sell |
-1,596
| Closed | -$13K | – | 2962 |
|
|
2019
Q3 | $13K | Buy |
1,596
+255
| +19% | +$1.9K | ﹤0.01% | 2279 |
|
|
2019
Q2 | $9K | Buy |
+1,341
| New | +$11.5K | ﹤0.01% | 2321 |
|
|
2017
Q4 | – | Sell |
-10,636
| Closed | -$388K | – | 2449 |
|
|
2017
Q3 | $388K | Buy |
+10,636
| New | +$329K | 0.01% | 1067 |
|
Squarepoint's AVEO Position: Q1 2023 in Review
Squarepoint sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 62,618 shares — an estimated $936K sold.
Squarepoint first reported a position in AVEO in Q3 2017 and held it in 8 quarters. The position peaked at $936K in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.
- Squarepoint reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Squarepoint sold 62,618 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $936K.
- Squarepoint first reported a position in AVEO Pharmaceuticals, Inc. in Q3 2017 and held it in 8 quarters.
- Squarepoint's AVEO Pharmaceuticals, Inc. position peaked at $936K in Q4 2022.
- 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.
Based on Squarepoint's 13F filing for Q1 2023, filed 15 May 2023.